DRREDDYBSEDr Reddys Laboratories LtdMinimalNeutral
Announced Thu, 28 May · 16:38 IST

Annual Secretarial Compliance certificate for the year ended March 31, 2026

DRREDDY · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve 14 horizons · vs prior close
-2.5%1-day move
₹1320.00
prior close
₹1318.80
base price
After-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
+0.1+0.1+0.0-0.7-2.5-3.3-4.4-3.9-2.8-3.8-4.0+4.5
Up moveDown movePending
AI summary

Dr. Reddy's Laboratories has received a clean annual secretarial compliance certificate for FY 2025-26 from practicing company secretaries Makarand M. Joshi & Co. The certification confirms the company complied with all applicable SEBI regulations including the Listing Regulations, ICDR Regulations, SAST Regulations, Share Based Employee Benefits Regulations, and Insider Trading Regulations. No deviations, penalties, or regulatory actions were reported against the company, its promoters, directors, or subsidiaries during the review period. All 13 compliance checkpoints including secretarial standards, policy adoption, website disclosures, director disqualification checks, subsidiary compliance, document preservation, performance evaluations, related party transactions, and insider trading norms showed full compliance. No previous report observations required remediation.

Likely market impact

This clean compliance report is positive for shareholders as it confirms Dr. Reddy's maintained strong corporate governance standards with no regulatory issues during the fiscal year, reinforcing investor confidence in the company's adherence to SEBI norms.